Abstract:AimsCopy number variant-sequencing (CNV-seq) and exome sequencing (ES) have been used as powerful tools in understanding the role of genetic variants in congenital heart diseases (CHDs). A few previous large cohort studies have utilized CNV-seq and ES to investigate prenatally diagnosed CHD. Here, we sought to determine the value of CNV-seq and ES for genetic evaluation of foetal CHDs. Methods and resultsWe recruited 398 pregnant women diagnosed with CHDs between 8 January 2017 and 30 November 2020. CNV-seq and ES were performed on foetal and parent samples. CHD cases were classified following the guidelines of the International Paediatric and Congenital Cardiac Code and the Tenth and Eleventh Revisions of the International Classification of Diseases. Data on aneuploids (AUP), pathogenic CNVs (pCNVs), and single nucleotide variants (SNVs) were collected and compared, following appropriate procedures. We identified genetic abnormalities in 129 (32.41%) foetuses. These abnormalities included AUP (10.80%), pCNVs (13.32%), and SNVs (8.04%). ES analysis yielded higher SNVs in cases without AUP or pCNVs. Non-isolated CHDs were associated with higher genetic abnormalities than isolated CHDs, mainly due to AUP differences between the two groups. The prevalence of genetic defects was the highest in foetuses with atrioventricular septal defects (AVSD), left ventricular outflow tract obstruction (LVOTO), and conotruncal defects (CTD). AVSD and anomalies of atrioventricular junctions and valves were associated with AUP abnormalities. CTD, anomalies of extrapericardial arterial trunks, and anomalies of the ventricular outflow tracts were the most common CHD categories diagnosed using CNVs. The most common CHDs associated with single ventricle (SV) abnormalities were heterotaxy (Hex) (14.89%), LVOTO (14.58%), and ventricular septal defect (VSD) (26.67%, 4/15). Although the ES yields were higher than CNV-seq for VSD (44.4%, 4/9), LVOTO (20%, 7/35), Hex (14.89%, 7/47), and CTD (9.1%, 11/121), its diagnostic yield did not increase for SV (6.7%, 1/15), AVSD (3.8%, 1/26), or right ventricular obstruction defects (2.6%, 1/38). The most common mutations were observed in KMT2D, CHD7, and NOTCH1. ConclusionsTo our knowledge, this is the largest cohort study to investigate the incidence of SNVs using ES in foetal CHD. CNV-seq and ES identified genetic abnormalities in nearly 1/3 of foetal CHD cases. Thus, CNV-seq and ES can provide clinically relevant information for pregnancy management.

The Genetic Architecture of Congenital Heart Disease in Neonatal Intensive Care Unit Patients-The Experience of University Medical Centre, Ljubljana

Genetic Architecture in Neonatal Intensive Care Unit Patients with Congenital Heart Defects: a Retrospective Study from the China Neonatal Genomes Project.

Genomic testing and molecular diagnosis among infants with congenital heart disease in the neonatal intensive care unit

Genetic Analysis Algorithm for the Study of Patients with Multiple Congenital Anomalies and Isolated Congenital Heart Disease

Chromosome Microarray Testing for Patients with Congenital Heart Defects Reveals Novel Disease Causing Loci and High Diagnostic Yield

Genetic Contribution to Congenital Heart Disease (CHD)

The Impact of Integration of a Genetic Clinic Into a Pediatric Cardiac Unit

A Pilot Study of Multiplex Ligation-Dependent Probe Amplification Evaluation of Copy Number Variations in Romanian Children with Congenital Heart Defects

Genetic aetiology distribution of 398 foetuses with congenital heart disease in the prenatal setting

Current approach to genetic testing and genetic evaluation referrals for adults with congenital heart disease

Prenatal chromosomal microarray analysis in fetuses with congenital heart disease: a prospective cohort study

Clinical Application of Chromosomal Microarray Analysis in Fetuses with Congenital Heart Disease

Prenatal diagnosis and prevalence of critical congenital heart defects: an international retrospective cohort study

[Prenatal Genetic Study of Fetuses with Congenital Heart Diseases].

Clinical Decision Analysis of Genetic Evaluation and Testing in 1013 Intensive Care Unit Infants with Congenital Heart Defects Supports Universal Genetic Testing

Detection of copy number variants using chromosomal microarray analysis for the prenatal diagnosis of congenital heart defects with normal karyotype.

Genomic insights into prenatal diagnosis of congenital heart defects: value of CNV-seq and WES in clinical practice

Clinical Application Of Chromosomal Microarray Analysis For The Prenatal Diagnosis Of Chromosomal Abnormalities And Copy Number Variations In Fetuses With Congenital Heart Disease (Vol 38, Pg 406, 2018)

Morbidity and mortality in premature or low birth weight patients with congenital heart disease in three European pediatric heart centers between 2016 and 2020

Detection of Submicroscopic Chromosomal Aberrations by Array‐based Comparative Genomic Hybridization in Fetuses with Congenital Heart Disease

Incidence and types of congenital heart disease at a referral hospital in Jordan: retrospective study from a tertiary center